M&A Deal Summary

Revive Personal Products Acquires The Natural Dentist

On February 23, 2010, Revive Personal Products acquired consumer products company The Natural Dentist from Aisling Capital

Acquisition Highlights
  • This is Revive Personal Products’ 1st transaction in the Consumer Products sector.
  • This is Revive Personal Products’ 1st transaction in the United States.
  • This is Revive Personal Products’ 1st transaction in Massachusetts.

M&A Deal Summary

Date 2010-02-23
Target The Natural Dentist
Sector Consumer Products
Buyer(s) Revive Personal Products
Sellers(s) Aisling Capital
Deal Type Add-on Acquisition

Target

The Natural Dentist

Medford, Massachusetts, United States
The Natural Dentist, Inc. is a manufacturer of natural dental products for the mass market. The Natural Dentist is based in Medford, Massachusetts.

Search 214,239 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Revive Personal Products

Madison, New Jersey, United States

Category Company
Founded 2008
Sector Consumer Products
DESCRIPTION

Revive Personal Products is an operator and marketer of over-the-counter (OTC) consumer healthcare brands including Stim-U-Dent®, The Natural Dentist®, Fresh ‘n Brite®, Healthy Woman®, Conceptrol®, and Gynol II®. Revive Personal Products was founded in 2008 and is based in Madison, New Jersey.


DEAL STATS #
Overall 1 of 1
Sector: Consumer Products M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
State: Massachusetts M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2010 M&A 1 of 1

Seller(S) 1

SELLER

Aisling Capital

New York, New York, United States

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 2000
PE ASSETS 1.8B USD
Size Large
Type Sector Focused
DESCRIPTION

Aisling Capital is a private investment firm focused on opportunities in the healthcare and medical technology sectors. The Firm specifically looks to invest in companies developing and commercializing innovative healthcare products, services, and technologies. Aisling Capital looks to commit $20 to $50 million per investment and prefers to be the lead investor. Aisling will consider investing in both public and private companies. Aisling Capital raised its first fund in 2000. The Firm is based in New York City.


DEAL STATS #
Overall 13 of 41
Sector: Consumer Products M&A 1 of 2
Type: Add-on Acquisition M&A Deals 12 of 24
State: Massachusetts M&A 1 of 2
Country: United States M&A 13 of 41
Year: 2010 M&A 2 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2010-01-19 Sirion Therapeutics

Tampa, Florida, United States

Specialty pharmaceutical company focused on the development and commercialization of drugs for ophthalmic indications.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2010-04-22 Aragon Pharmaceuticals

San Diego, California, United States

Aragon Pharmaceuticals is a privately held, small-molecule drug discovery company focused on developing breakthrough medicines for the treatment of hormonally-driven cancers.

Buy -